Filtyp
Petersén is invited to give a talk at the 2025 Family Gathering for the Scottish Huntington's Association with around 170 attendees on November 8, 2025 in Glasgow.Link to the programme at the association’s webpage (opens in a new window)
https://www.huntington-research.lu.se/article/petersen-gives-talk-scottish-huntingtons-association-meeting - 2026-07-23
The Swedish patients' organisation, RHS, held their yearly meeting in October 2025 and Professor Åsa Petersén was invited speaker. Petersén's talk addressed early symptoms in HD connected to research. The meeting was recorded and the films are now available on RHS' website.Link to the content at RHS' website - in Swedish only (opens in a new window)
https://www.huntington-research.lu.se/article/petersens-talk-rhs-meeting-2025 - 2026-07-23
Jennifer Oraha, PhD student in Åsa Peterséns's research group, has her first publication out. The article is based on her study of the effects of overexpression of TDP-43 or mHTT in AgRP-expressing neurons on metabolic, behavioral and neuropathological features in mice.FTD/ALS and HD share early traits when it comes to altered metabolism and psychiatric symtoms, and it has been suggested that thes
https://www.huntington-research.lu.se/article/congratulations-jennifer-her-first-publication-phd-student - 2026-07-23
Åsa Petersén has been interviewed by the website “Vetenskap & Hälsa” (Science & Health) about Huntington’s disease and the ongoing research to find a future treatment. Recent research has come up with some interesting findings, which are crucial for the development of efficient treatments.Link to the pod on the Vetenskap & Hälsa website – in Swedish only (opens in a new window)
https://www.huntington-research.lu.se/article/pod-huntingtons-disease-asa-petersen - 2026-07-23
For the first time ever, the four Swedish patients’ organizations for Alzheimer’s, Huntington, Parkinson’s and ALS are arranging a joint conference on neurodegenerative diseases. Åsa Petersén, Professor and Senior Consultant in Psychiatry, and Håkan Widner, Professor and Senior Consultant in Neurology, both active at the Huntington Disease Centre in Lund, will be taking part in a panel discussion
https://www.huntington-research.lu.se/article/mds-huntington-centre-lund-take-part-swedish-conference - 2026-07-23
After nearly four years' of PhD studies it is time for Sofia Bergh to defend her thesis in early May. Date and time: 6 May 2026 at 13.00Venue: The Belfrage Lecture Hall, BMC D15, Klinikgatan 32, LundAll welcome!
https://www.huntington-research.lu.se/article/sofia-bergh-phd-thesis-defence-6-may-2026 - 2026-07-23
On 6 May Sofia Bergh defended her thesis. The afternoon started with opponent Professor Gillian Bates, University College London, presenting the field of research and then Sofia talked about her published papers and work done during the PhD student years.Questions and discussion followed and then it was time for the examining committee deliberations. It was a fairly short meeting before the decisi
https://www.huntington-research.lu.se/article/congratulations-dr-bergh - 2026-07-23
From European Huntington Association:Join us for an open webinar with Novartis to get the latest updates on the INVEST-HD trial, including timeline updates and insights from a clinical perspective.Featuring presentations by Beth Borowsky, Senior Global Programme Clinical Head in Neuroscience at Novartis, and Åsa Petersén, MD PhD from Lund University, followed by a Q&A moderated by Astri Arnesen.📅
https://www.huntington-research.lu.se/article/dr-petersen-webinar-eha-and-novartis-invest-hd-trial - 2026-07-23
We are very happy to congratulate Jessica Giacomoni who on October 14th, 2022 successfully defended her thesis "Exploring Direct Conversion of Human Glia into Therapeutic Neurons". PhD interview: Turning glia into neurons inside the brain – PhD interview with Jessica Giacomoni Please click here to read the thesis.
https://www.regenerative-neurobiology.lu.se/article/congratulations-dr-giacomoni - 2026-07-23
Läkemedelsverket godkänner klinisk fas 1- och fas2a-studie för ny stamcellsbaserad behandling av Parkinsons sjukdom An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Authority, and the STEM-PD team, l
Lund University: Press release On 13th of February, 2023, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. Please go to the below links to find out more about STEM PD. English: https://www.lunduniversity.lu.se/article/first-patient-receives-milestone-stem-cell-based-transplant-parkinsons-disease Svenska: https://www.l
2023-04-27. We are very happy to join Fredrik Nilsson for the nailing of his thesis "Cell Replacement Therapy for Parkinson's Disease: Evaluating the potential of autologous grafting". The defence will take place on May 10th, 2023 at 9.00 am at the Belfrage Lecture Hall (Klinikgatan 32, Lund) - you are very welcome to join! To access the thesis please go to Lund university's database: Cell Replac
https://www.regenerative-neurobiology.lu.se/article/congratulations-fredrik - 2026-07-23
2023-05-10. We are very happy to announce that Fredrik Nilsson successfully defended his thesis "Cell Replacement Therapy for Parkinson's Disease: Evaluating the potential of autologous grafting" today. Congratulations Dr. Nilsson! To read an interview with Fredrik, please go to the following article: Investigating a cell replacement therapy for Parkinson's Disease: a Ph.D. Interview with Fredrik
https://www.regenerative-neurobiology.lu.se/article/congratulations-dr-nilsson - 2026-07-23
The prize was given in recognition of their pioneering work in researching neurodegenerative diseases and translational stem cell biology. For more information of the event, please see:https://www.dow.cam.ac.uk/news/experts-delve-advancements-parkinsons-treatment-oon-lecture
Positiva tidiga säkerhetsresultat har uppnåtts efter de fyra första patienterna som genomgått transplantation av dopaminproducerande stamceller inom den kliniska studien STEM-PD.För att läsa artikeln vänligen gå till: https://www.lu.se/artikel/klinisk-stamcellsbaserad-transplantationsstudie-stem-pd-mot-parkinsons-har-inlett-doshojning
För att gå till artikeln, vänligen besök DNs hemsida: https://www.dn.se/sverige/nya-celler-i-hjarnan-hopp-for-patienter-med-parkinsons-sjukdom/
För att se avsnittet, vänligen besök SVT Play: https://www.svtplay.se/video/jb3DV31/rapport/man-6-maj-19-30?position=1015&id=j7dJnd2Start: min. 16:59
https://www.regenerative-neurobiology.lu.se/article/svt-play-rapport-2024-05-06 - 2026-07-23
Malin Parmar, professor of cellular neuroscience, along with three researchers in Italy and Denmark, has been awarded the prestigious ERC Synergy Grant worth EUR 10 million. The four researchers aim to develop custom-made neurons from stem cells for cell therapies to treat Parkinson’s or Huntington’s disease. For full press release please go to the following page:https://www.lunduniversity.lu.se/a
This article is over 5 years old, and the information may therefore be outdated. Congratulations to Tiago Cardoso who "nailed" his thesis today! We are now very much looking forward to his defence which will take place on Nov 30th at 9.00 AM at BMC, D15, Belfrage Lecture Hall
https://www.regenerative-neurobiology.lu.se/article/congratulations-tiago-cardoso - 2026-07-23
This article is over 5 years old, and the information may therefore be outdated. Does it look different? Our new website has now been launched! We hope you will find it informative! Are you missing anything? Any mistakes? If so please contact Paulina.Pettersson@med.lu.se - we'll be thrilled to hear from you!
https://www.regenerative-neurobiology.lu.se/article/welcome-our-new-website - 2026-07-23
